SNRPCP6

Across TCGA pan-cancer cohorts, SNRPCP6 RNA differs between tumor and matched normal tissue in 3 of 18 cancer types tested, making tumor–normal expression one of SNRPCP6’s most consistent transcriptional readouts.

The strongest signal is observed in stomach adenocarcinoma (STAD), where SNRPCP6 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types SNRPCP6 is over-expressed in tumor, although a few such as BRCA show the opposite, repressed pattern.

STAD, BRCA, and CHOL are the cancer types where SNRPCP6 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in SNRPCP6 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
STAD	All	All	+0.159	.048	2	view →
BRCA	Female	All	−0.063	.035	2	view →
CHOL	All	All	+0.337	.038	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 3 strongest of 3 lineages.

SNRPCP6–STAD

Open the STAD breakdown →